Perspective Therapeutics, Inc. (CATX)

Perspective Therapeutics Market Cap

Perspective Therapeutics has a market cap or net worth of $991.89 million as of April 24, 2024. Its market cap has increased by 984.03% in one year.

• Market Cap: 991.89M
• Enterprise Value: 985.02M
• 1-Year Change: 984.03%
• Ranking: #2425
• Category: Small-Cap
• Stock Price: $1.69

Market Cap Chart

Since November 10, 2005, Perspective Therapeutics's market cap has increased from $49.80M to $991.89M, an increase of 1,891.74%. That is a compound annual growth rate of 17.59%.

Market Cap History

Date	Market Cap	% Change
Apr 23, 2024	997.80M	11.11%
Apr 22, 2024	898.00M	2.00%
Apr 19, 2024	880.40M	2.04%
Apr 18, 2024	862.80M	2.80%
Apr 17, 2024	839.30M	-2.05%
Apr 16, 2024	856.90M	-4.58%
Apr 15, 2024	898.00M	4.08%
Apr 12, 2024	862.80M	3.53%
Apr 11, 2024	833.40M	-6.58%
Apr 10, 2024	892.10M	-1.93%
Apr 9, 2024	909.70M	4.03%
Apr 8, 2024	874.50M	0.68%
Apr 5, 2024	868.60M	4.22%
Apr 4, 2024	833.40M	-1.40%
Apr 3, 2024	845.20M	-1.37%
Apr 2, 2024	856.90M	14.06%
Apr 1, 2024	751.30M	7.57%
Mar 28, 2024	698.40M	107.43%
Mar 27, 2024	336.70M	-3.22%
Mar 26, 2024	347.90M	-1.58%
Mar 25, 2024	353.50M	-0.79%
Mar 22, 2024	356.30M	-5.24%
Mar 21, 2024	376.00M	11.67%
Mar 20, 2024	336.70M	7.16%
Mar 19, 2024	314.20M	16.03%

View and export this data all the way back to 2005. Sign Up Today.

Related Stocks

Company	Market Cap
Silence Therapeutics	1.06B
Maravai LifeSciences Holdings	1.02B
MacroGenics	1.01B
Arcutis Biotherapeutics	1.00B
Abivax	997.87M
Alignment Healthcare	987.60M
Liquidia	984.56M
Standard BioTools	980.61M